{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T21:47:25Z","timestamp":1783720045056,"version":"3.55.0"},"reference-count":58,"publisher":"Impact Journals, LLC","issue":"24","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,12,31]]},"DOI":"10.18632\/aging.104136","type":"journal-article","created":{"date-parts":[[2020,11,21]],"date-time":"2020-11-21T05:56:00Z","timestamp":1605938160000},"page":"25337-25355","source":"Crossref","is-referenced-by-count":17,"title":["Single cell sequencing reveals cell populations that predict primary resistance to imatinib in chronic myeloid leukemia"],"prefix":"10.18632","volume":"12","author":[{"given":"Weilong","family":"Zhang","sequence":"first","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, China"},{"name":"State Key Lab of Molecular Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beibei","family":"Yang","sequence":"additional","affiliation":[{"name":"State Key Lab of Molecular Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linqian","family":"Weng","sequence":"additional","affiliation":[{"name":"Department of Hematology, Beijing Hospital, National Center of Gerontology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiangtao","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Hematology, Beijing Hospital, National Center of Gerontology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiefei","family":"Bai","sequence":"additional","affiliation":[{"name":"Department of Hematology, Beijing Hospital, National Center of Gerontology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ting","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Beijing Hospital, National Center of Gerontology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingwen","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin","family":"Ye","sequence":"additional","affiliation":[{"name":"Department of Hematology, Beijing Tongren Hospital, Capital Medical University, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongmei","family":"Jing","sequence":"additional","affiliation":[{"name":"Department of Hematology, Lymphoma Research Center, Peking University Third Hospital, Beijing 100191, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuchen","family":"Jiao","sequence":"additional","affiliation":[{"name":"State Key Lab of Molecular Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xixi","family":"Chen","sequence":"additional","affiliation":[{"name":"Genetron Health (Beijing) Co. Ltd., Beijing 102206, China"},{"name":"Children\u2019s Hospital of Chongqing Medical University, Chongqing 400014, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Liu","sequence":"additional","affiliation":[{"name":"Department of Hematology, Beijing Hospital, National Center of Gerontology, Beijing, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Xin","family":"Zeng","sequence":"additional","affiliation":[{"name":"State Key Lab of Molecular Oncology, National Cancer Center\/National Clinical Research Center for Cancer\/Cancer Hospital, Chinese Academy of Medical Sciences and Peking Union Medical College, Beijing 100021, China"},{"name":"Department of Experimental Research, Sun Yat-sen University Cancer Center, State Key Laboratory of Oncology in Southern China, Collaborative Innovation Center for Cancer Medicine, Guangzhou, Guangdong Province, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"7892","published-online":{"date-parts":[[2020,11,23]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/leu.2015.261","article-title":"Prognosis of long-term survival considering disease-specific death in patients with chronic myeloid leukemia.","volume":"3","author":"Simonsson","year":"2016","journal-title":"Leukemia"},{"key":"2","doi-asserted-by":"publisher","first-page":"585","DOI":"10.1038\/leu.2016.231","article-title":"Cytogenetic landscape and impact in blast phase of chronic myeloid leukemia in the era of tyrosine kinase inhibitor therapy.","volume":"3","author":"Hu","year":"2017","journal-title":"Leukemia"},{"key":"3","doi-asserted-by":"publisher","first-page":"507","DOI":"10.1038\/sj.leu.2403664","article-title":"Monitoring patients in complete cytogenetic remission after treatment of CML in chronic phase with imatinib: patterns of residual leukaemia and prognostic factors for cytogenetic relapse.","volume":"1","author":"Apperley","year":"2005","journal-title":"Leukemia"},{"key":"4","doi-asserted-by":"publisher","first-page":"876","DOI":"10.1126\/science.1062538","article-title":"Clinical resistance to STI-571 cancer therapy caused by BCR-ABL gene mutation or amplification.","volume":"29","author":"Sawyers","year":"2001","journal-title":"Science"},{"key":"5","doi-asserted-by":"publisher","first-page":"76","DOI":"10.1159\/000046636","article-title":"Cytogenetic and molecular genetic evolution of chronic myeloid leukemia.","volume":"10","author":"Mitelman","year":"2002","journal-title":"Acta Haematol"},{"key":"6","doi-asserted-by":"publisher","first-page":"1870","DOI":"10.1002\/eji.201142043","article-title":"Evidence for BCR-ABL-dependent dysfunctions of iNKT cells from chronic myeloid leukemia patients.","volume":"4","author":"Gombert","year":"2012","journal-title":"Eur J Immunol"},{"key":"7","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1038\/leu.2011.239","article-title":"NK cells are dysfunctional in human chronic myelogenous leukemia before and on imatinib treatment and in BCR-ABL-positive mice.","volume":"2","author":"Rossig","year":"2012","journal-title":"Leukemia"},{"key":"8","doi-asserted-by":"publisher","first-page":"e55818","DOI":"10.1371\/journal.pone.0055818","article-title":"Increased level of myeloid-derived suppressor cells, programmed death receptor ligand 1\/programmed death receptor 1, and soluble CD25 in sokal high risk chronic myeloid leukemia.","volume":"8","author":"Loskog","year":"2013","journal-title":"PLoS One"},{"key":"9","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1080\/14653240802317639","article-title":"Immunomodulatory effects of imatinib and second-generation tyrosine kinase inhibitors on T cells and dendritic cells: an update.","volume":"1","author":"Purbhoo","year":"2008","journal-title":"Cytotherapy"},{"key":"10","doi-asserted-by":"publisher","first-page":"836","DOI":"10.1038\/s41556-018-0121-4","article-title":"Single-cell characterization of haematopoietic progenitors and their trajectories in homeostasis and perturbed haematopoiesis.","volume":"2","author":"Amit","year":"2018","journal-title":"Nat Cell Biol"},{"key":"11","doi-asserted-by":"publisher","first-page":"1663","DOI":"10.1016\/j.cell.2015.11.013","article-title":"Transcriptional heterogeneity and lineage commitment in myeloid progenitors.","volume":"16","author":"Lauridsen","year":"2015","journal-title":"Cell"},{"key":"12","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1038\/ncb3493","article-title":"Human haematopoietic stem cell lineage commitment is a continuous process.","volume":"1","author":"Ho","year":"2017","journal-title":"Nat Cell Biol"},{"key":"13","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1038\/nm.4336","article-title":"Single-cell transcriptomics uncovers distinct molecular signatures of stem cells in chronic myeloid leukemia.","volume":"2","author":"Anderson","year":"2017","journal-title":"Nat Med"},{"key":"14","doi-asserted-by":"publisher","first-page":"2384","DOI":"10.1182\/blood-2016-07-728873","article-title":"Single-cell molecular analysis defines therapy response and immunophenotype of stem cell subpopulations in CML.","volume":"12","author":"Karlsson","year":"2017","journal-title":"Blood"},{"key":"15","doi-asserted-by":"publisher","first-page":"2395","DOI":"10.1038\/s41467-019-10291-0","article-title":"A comprehensive single cell transcriptional landscape of human hematopoietic progenitors.","volume":"1","author":"Biasco","year":"2019","journal-title":"Nat Commun"},{"key":"16","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1038\/ni749","article-title":"CD99 plays a major role in the migration of monocytes through endothelial junctions.","volume":"3","author":"Muller","year":"2002","journal-title":"Nat Immunol"},{"key":"17","doi-asserted-by":"publisher","first-page":"eaaj2025","DOI":"10.1126\/scitranslmed.aaj2025","article-title":"CD99 is a therapeutic target on disease stem cells in myeloid Malignancies.","volume":"9","author":"Park","year":"2017","journal-title":"Sci Transl Med"},{"key":"18","doi-asserted-by":"publisher","first-page":"2578","DOI":"10.1182\/blood-2005-12-010827","article-title":"CD99 expressed on human mobilized peripheral blood CD34+ cells is involved in transendothelial migration.","volume":"10","author":"Chabannon","year":"2006","journal-title":"Blood"},{"key":"19","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1007\/s12079-017-0445-z","article-title":"CD99 at the crossroads of physiology and pathology.","volume":"1","author":"Scotlandi","year":"2018","journal-title":"J Cell Commun Signal"},{"key":"20","doi-asserted-by":"publisher","first-page":"1090","DOI":"10.1038\/onc.2015.174","article-title":"Role of HOXA9 in leukemia: dysregulation, cofactors and essential targets.","volume":"3","author":"Hess","year":"2016","journal-title":"Oncogene"},{"key":"21","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1016\/j.ccell.2018.08.018","article-title":"HOXA9 reprograms the enhancer landscape to promote leukemogenesis.","volume":"3","author":"Dressler","year":"2018","journal-title":"Cancer Cell"},{"key":"22","doi-asserted-by":"publisher","first-page":"1371","DOI":"10.1124\/dmd.109.031302","article-title":"Comparison of ATP-binding cassette transporter interactions with the tyrosine kinase inhibitors imatinib, nilotinib, and dasatinib.","volume":"3","author":"Bates","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"23","doi-asserted-by":"publisher","first-page":"54","DOI":"10.1038\/nature25741","article-title":"Population snapshots predict early haematopoietic and erythroid hierarchies.","volume":"55","author":"Socolovsky","year":"2018","journal-title":"Nature"},{"key":"24","doi-asserted-by":"publisher","first-page":"e1000484","DOI":"10.1371\/journal.pbio.1000484","article-title":"A key commitment step in erythropoiesis is synchronized with the cell cycle clock through mutual inhibition between PU.1 and s-phase progression.","volume":"8","author":"Socolovsky","year":"2010","journal-title":"PLoS Biol"},{"key":"25","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1158\/0008-5472.CAN-14-3625","article-title":"SOCS2 controls proliferation and stemness of hematopoietic cells under stress conditions and its deregulation marks unfavorable acute leukemias.","volume":"7","author":"Tripodo","year":"2015","journal-title":"Cancer Res"},{"key":"26","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/j.bbrc.2003.11.115","article-title":"S100A16, a ubiquitously expressed EF-hand protein which is up-regulated in tumors.","volume":"31","author":"Heizmann","year":"2004","journal-title":"Biochem Biophys Res Commun"},{"key":"27","doi-asserted-by":"publisher","first-page":"1175","DOI":"10.1016\/j.neo.2018.09.007","article-title":"S100 proteins in acute myeloid leukemia.","volume":"2","author":"Bruserud","year":"2018","journal-title":"Neoplasia"},{"key":"28","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1182\/blood-2009-03-210732","article-title":"A gene expression signature of CD34+ cells to predict major cytogenetic response in chronic-phase chronic myeloid leukemia patients treated with imatinib.","volume":"11","author":"O\u2019Brien","year":"2010","journal-title":"Blood"},{"key":"29","doi-asserted-by":"publisher","first-page":"1610","DOI":"10.1182\/bloodadvances.2019000195","article-title":"Gene expression signature that predicts early molecular response failure in chronic-phase CML patients on frontline imatinib.","volume":"3","author":"Hughes","year":"2019","journal-title":"Blood Adv"},{"key":"30","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1179\/1607845413Y.0000000094","article-title":"Protein-coding genes and long noncoding RNAs are differentially expressed in dasatinib-treated chronic myeloid leukemia patients with resistance to imatinib.","volume":"1","author":"Pagnano","year":"2014","journal-title":"Hematology"},{"key":"31","doi-asserted-by":"publisher","first-page":"2794","DOI":"10.1073\/pnas.0510423103","article-title":"Gene expression changes associated with progression and response in chronic myeloid leukemia.","volume":"10","author":"Linsley","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"32","doi-asserted-by":"publisher","first-page":"745","DOI":"10.1189\/jlb.3MR0214-109R","article-title":"Complement modulation of T cell immune responses during homeostasis and disease.","volume":"9","author":"Tenner","year":"2014","journal-title":"J Leukoc Biol"},{"key":"33","doi-asserted-by":"publisher","first-page":"558","DOI":"10.1126\/science.aao4555","article-title":"C1q restrains autoimmunity and viral infection by regulating CD8T cell metabolism.","volume":"36","author":"Botto","year":"2018","journal-title":"Science"},{"key":"34","doi-asserted-by":"publisher","first-page":"7783","DOI":"10.1073\/pnas.1722056115","article-title":"CD52 glycan binds the proinflammatory B box of HMGB1 to engage the siglec-10 receptor and suppress human T cell function.","volume":"11","author":"Hartley-Tassell","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"35","doi-asserted-by":"publisher","first-page":"675","DOI":"10.1038\/319675a0","article-title":"Selective rejection of H-2-deficient lymphoma variants suggests alternative immune defence strategy.","volume":"31","author":"Kiessling","year":"1986","journal-title":"Nature"},{"key":"36","doi-asserted-by":"publisher","first-page":"553","DOI":"10.1111\/j.1399-0039.2009.01235.x","article-title":"Killer immunoglobulin-like receptors (KIR2DL2 and\/or KIR2DS2) in presence of their ligand (HLA-C1 group) protect against chronic myeloid leukaemia.","volume":"7","author":"Gourraud","year":"2009","journal-title":"Tissue Antigens"},{"key":"37","doi-asserted-by":"publisher","first-page":"3969","DOI":"10.4049\/jimmunol.180.6.3969","article-title":"Synergistic polymorphism at two positions distal to the ligand-binding site makes KIR2DL2 a stronger receptor for HLA-C than KIR2DL3.","volume":"18","author":"Parham","year":"2008","journal-title":"J Immunol"},{"key":"38","doi-asserted-by":"publisher","first-page":"381","DOI":"10.11406\/rinketsu.58.381","article-title":"[Chronic myeloid leukemia and NK cell immunity].","volume":"5","author":"Kimura","year":"2017","journal-title":"Rinsho Ketsueki"},{"key":"39","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1038\/nm.4310","article-title":"Targeting c-FOS and DUSP1 abrogates intrinsic resistance to tyrosine-kinase inhibitor therapy in BCR-ABL-induced leukemia.","volume":"2","author":"Azam","year":"2017","journal-title":"Nat Med"},{"key":"40","doi-asserted-by":"publisher","first-page":"494","DOI":"10.1038\/sj.leu.2404549","article-title":"Molecular signature of CD34(+) hematopoietic stem and progenitor cells of patients with CML in chronic phase.","volume":"2","author":"Kobbe","year":"2007","journal-title":"Leukemia"},{"key":"41","doi-asserted-by":"publisher","first-page":"892","DOI":"10.1038\/leu.2008.392","article-title":"The hematopoietic stem cell in chronic phase CML is characterized by a transcriptional profile resembling normal myeloid progenitor cells and reflecting loss of quiescence.","volume":"2","author":"Kobbe","year":"2009","journal-title":"Leukemia"},{"key":"42","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1038\/s41586-020-1943-3","article-title":"The repertoire of mutational signatures in human cancer.","volume":"57","author":"Klimczak","year":"2020","journal-title":"Nature"},{"key":"43","doi-asserted-by":"publisher","first-page":"8755","DOI":"10.1093\/nar\/gku554","article-title":"Transition-state destabilization reveals how human DNA polymerase \u03b2 proceeds across the chemically unstable lesion N7-methylguanine.","volume":"4","author":"Lee","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"44","doi-asserted-by":"publisher","first-page":"14067","DOI":"10.1021\/jacs.5b10172","article-title":"N7 methylation alters hydrogen-bonding patterns of guanine in duplex DNA.","volume":"13","author":"Lee","year":"2015","journal-title":"J Am Chem Soc"},{"key":"45","doi-asserted-by":"publisher","first-page":"627","DOI":"10.2217\/nnm-2018-0147","article-title":"Nanoparticle systems for cancer vaccine.","volume":"1","author":"Farooqi","year":"2019","journal-title":"Nanomedicine (Lond)"},{"key":"46","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1007\/978-3-319-91442-8_16","article-title":"Gefitinib.","volume":"21","author":"Waller","year":"2018","journal-title":"Recent Results Cancer Res"},{"key":"47","doi-asserted-by":"publisher","first-page":"32","DOI":"10.1016\/j.coph.2015.05.011","article-title":"PD-1\/PD-L1 inhibitors.","volume":"2","author":"Taube","year":"2015","journal-title":"Curr Opin Pharmacol"},{"key":"48","doi-asserted-by":"publisher","first-page":"442","DOI":"10.1002\/ajh.25011","article-title":"Chronic myeloid leukemia: 2018 update on diagnosis, therapy and monitoring.","volume":"9","author":"Kantarjian","year":"2018","journal-title":"Am J Hematol"},{"key":"49","doi-asserted-by":"publisher","first-page":"288ra78","DOI":"10.1126\/scitranslmed.aaa7014","article-title":"Adoptive transfer of activated marrow-infiltrating lymphocytes induces measurable antitumor immunity in the bone marrow in multiple myeloma.","volume":"7","author":"Rosner","year":"2015","journal-title":"Sci Transl Med"},{"key":"50","doi-asserted-by":"publisher","first-page":"495","DOI":"10.1038\/nbt.3192","article-title":"Spatial reconstruction of single-cell gene expression data.","volume":"3","author":"Regev","year":"2015","journal-title":"Nat Biotechnol"},{"key":"51","doi-asserted-by":"publisher","first-page":"1888","DOI":"10.1016\/j.cell.2019.05.031","article-title":"Comprehensive integration of single-cell data.","volume":"17","author":"Satija","year":"2019","journal-title":"Cell"},{"key":"52","doi-asserted-by":"publisher","first-page":"38","DOI":"10.1038\/nbt.4314","article-title":"Dimensionality reduction for visualizing single-cell data using UMAP.","volume":"3","author":"Newell","year":"2019","journal-title":"Nat Biotechnol"},{"key":"53","doi-asserted-by":"publisher","first-page":"15545","DOI":"10.1073\/pnas.0506580102","article-title":"Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles.","volume":"10","author":"Mesirov","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"54","doi-asserted-by":"publisher","first-page":"7","DOI":"10.1186\/1471-2105-14-7","article-title":"GSVA: gene set variation analysis for microarray and RNA-seq data.","volume":"1","author":"Guinney","year":"2013","journal-title":"BMC Bioinformatics"},{"key":"55","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1016\/j.cels.2015.12.004","article-title":"The molecular signatures database (MSigDB) hallmark gene set collection.","volume":"1","author":"Tamayo","year":"2015","journal-title":"Cell Syst"},{"key":"56","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1038\/s41586-018-0698-6","article-title":"Single-cell reconstruction of the early maternal-fetal interface in humans.","volume":"56","author":"Henriksson","year":"2018","journal-title":"Nature"},{"key":"57","doi-asserted-by":"publisher","first-page":"979","DOI":"10.1038\/nmeth.4402","article-title":"Reversed graph embedding resolves complex single-cell trajectories.","volume":"1","author":"Trapnell","year":"2017","journal-title":"Nat Methods"},{"key":"58","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1038\/nbt.2859","article-title":"The dynamics and regulators of cell fate decisions are revealed by pseudotemporal ordering of single cells.","volume":"3","author":"Rinn","year":"2014","journal-title":"Nat Biotechnol"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.104136","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,4,6]],"date-time":"2021-04-06T15:56:49Z","timestamp":1617724609000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.104136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,23]]},"references-count":58,"journal-issue":{"issue":"24","published-print":{"date-parts":[[2020,12,31]]}},"alternative-id":["104136","33226961"],"URL":"https:\/\/doi.org\/10.18632\/aging.104136","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,23]]}}}